Furthermore, hyperglycemia upregulates glucose transporters (GLUT1 and GLUT3), thus further amplifying glucose uptake in certain cancers, a potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy [26]. The gene discussed is SLC2A3; the disease is cancer.